Rallybio Corporation
About
14.52USD-0.01 -0.07%
Closed • Updated at 08:05 GMT+00:00Market Cap$76.93M
Volume21.4K
Beta0.98
RSI65.45
Gross Margin92.19%
Rallybio Corporation — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 2 2026
Rallybio Corporation and Candid Therapeutics Announce Merger Agreement
Feb 17 2026
Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
Feb 3 2026
Rallybio Announces Reverse Stock Split of Common Stock
Nov 6 2025
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
Sep 25 2025
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
Recent Videos
RLYB STOCK : FRESH BREAKOUT | RALLYBIO STOCK
May 05, 2026
RLYB Stock Update | Rallybio Corp Stock Technical Analysis and Future Outlook
May 04, 2026
RLYB STOCK : POTENTIAL RECOVERY | RALLYBIO STOCK
Mar 27, 2026
BIG PRICE RECOVERY | RLYB STOCK ANALYSIS | RALLYBIO STOCK
Mar 05, 2026
Community Chat
Ask AI
Try asking